# Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children

> **NCT00453856** · PHASE4 · TERMINATED · sponsor: **Albert Schweitzer Hospital, Netherlands** · enrollment: 139 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Sulfadoxine Pyrimethamine

## Key facts

- **NCT ID:** NCT00453856
- **Lead sponsor:** Albert Schweitzer Hospital, Netherlands
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 139 (ESTIMATED)
- **Why stopped:** The study was terminated because of Early Treatment Failure in child.The justification for this decision are concerns about safety of children.
- **Last updated:** 2007-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453856, "Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00453856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*